Question 1

What is Flecainide?

Accepted Answer

Flecainide is a prescription medication classified as an antiarrhythmic. It works by affecting the electrical signals in the heart to help stabilize the heart's rhythm.

This medication is used to manage certain types of irregular heartbeats. By slowing these electrical signals, it helps the heart maintain a regular and steady beat.

Question 2

What is Flecainide used for?

Accepted Answer

Flecainide is used to treat life-threatening ventricular arrhythmias .

Question 3

How does Flecainide work?

Accepted Answer

How Flecainide Works

Flecainide belongs to a class of medications known as antiarrhythmics. It is used to treat and prevent certain types of serious irregular heartbeats by regulating the electrical activity within the heart muscle.

The heart relies on internal electrical impulses to tell the heart muscle when to contract and pump blood. These signals travel through the heart via specialized pathways. Flecainide works through the following mechanisms:

Sodium channel blockade: It works by blocking the flow of sodium into the heart cells. Sodium is essential for creating and conducting the electrical signals that trigger a heartbeat.

Slowing conduction: By interfering with these sodium channels, the medication slows the speed at which electrical impulses travel through the heart tissue.

Stabilizing heart rhythm: This slowing effect helps the heart maintain a regular rhythm and prevents abnormal or rapid electrical signals from causing an irregular heartbeat (arrhythmia).

By acting directly on the heart tissue to manage these nerve impulses, flecainide helps the heart beat in a more stable and predictable pattern.

Question 4

What are the brand names for Flecainide?

Accepted Answer

Flecainide is sold under the brand names Tambocor , Tambacor , and Flecainide Acetate .

Question 5

What are the active ingredients in Flecainide?

Accepted Answer

The active ingredient in Flecainide is flecainide .

Question 6

What are the side effects of Flecainide?

Accepted Answer

Common side effects of Flecainide may include:

dizziness

visual disturbances

shortness of breath

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Flecainide?

Accepted Answer

Flecainide belongs to the Class IC antiarrhythmic drug class.

Question 8

What is the dosage of Flecainide and how do I take it?

Accepted Answer

How to Take

Flecainide is available as a tablet to be taken by mouth. It is usually taken twice a day, approximately every 12 hours. You may take this medication with or without food, but it is important to be consistent in how you take it. To help maintain a steady level of the drug in your bloodstream, try to take your doses at the same times each day.

Starting Treatment

When you first begin taking flecainide or when your dose is adjusted, your healthcare provider may require you to stay in a hospital. This allows medical staff to monitor your heart rhythm and response to the medication using an electrocardiogram (ECG).

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once to make up for a missed one.

Important Considerations

Do not stop taking flecainide or change your dose without consulting your doctor, even if you feel well. Stopping the medication suddenly can cause your heart rhythm problems to return.

Question 9

Is Flecainide safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of flecainide use in pregnant women. In animal studies, high doses of the medication were associated with birth defects and fetal harm. Because flecainide is known to cross the placenta, it should be used during pregnancy only if the potential benefit justifies the potential risk to the developing fetus. If you are pregnant or planning to become pregnant, discuss the risks and benefits of this medication with your healthcare provider.

Breastfeeding

Flecainide is excreted into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, a decision should be made whether to discontinue breastfeeding or discontinue the medication. This decision should take into account the importance of the drug to the mother's health. Consult your doctor to determine the safest course of action for you and your baby.

Question 10

What forms and strengths does Flecainide come in?

Accepted Answer

Available Forms

Flecainide is available in the following form:

Oral Tablet: This medication is taken by mouth.

Question 11

What is the FDA approval status of Flecainide?

Accepted Answer

FDA Approval and Indications

Flecainide is approved by the FDA for the prevention of certain types of irregular heartbeats, including paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation or flutter (PAF) in patients without structural heart disease. It is also indicated for the treatment of documented, life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia.

Boxed Warning

The FDA has issued a boxed warning for flecainide based on findings from the Cardiac Arrhythmia Suppression Trial (CAST). This trial demonstrated that in patients with a recent heart attack (occurring between six days and two years prior) who had non-life-threatening ventricular arrhythmias, flecainide was associated with an increased risk of death or non-fatal cardiac arrest compared to a placebo.

Safety and Regulatory Restrictions

Flecainide has proarrhythmic effects, meaning it has the potential to cause new or worsened heart rhythm disturbances. Because of these risks, the FDA recommends that flecainide use be restricted to patients with life-threatening arrhythmias or highly symptomatic supraventricular arrhythmias where the benefits outweigh the potential risks.

Regulatory guidelines generally advise against the use of flecainide in patients with structural heart disease, such as those with a history of congestive heart failure or a previous myocardial infarction, due to the heightened risk of proarrhythmia and mortality in these groups.

Question 12

What should I know about Flecainide and fda?

Accepted Answer

The U.S. Food and Drug Administration (FDA) has approved flecainide for the following uses:

Prevention of paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.

Prevention of paroxysmal atrial fibrillation or flutter (PAF) in patients who do not have structural heart disease.

Treatment of documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia.

Flecainide carries a boxed warning, the FDA's most serious warning, regarding its use in certain populations. Clinical trials found that patients with a recent heart attack who took flecainide had a higher risk of death or non-fatal cardiac arrest compared to those taking a placebo. Because of these risks, the FDA restricts its use to patients with the specific heart rhythm disorders listed above and generally advises against its use in patients with structural heart disease or recent heart attacks.

Flecainide was first approved by the FDA in 1985. It is classified as a Class IC antiarrhythmic agent. Due to the potential for serious side effects, the FDA recommends that treatment, particularly for certain ventricular arrhythmias, be started in a hospital setting where the patient's heart rhythm can be continuously monitored.

Flecainide

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Fda Information

FAQ

Found an Error?